Microarray Scanners Market is projected to expand at a CAGR of ~7% from 2020 to 2030

Microarray Scanners Market: Introduction

According to the report, the global microarray scanners market was valued at US$ 700 Mn in 2019 and is projected to expand at a CAGR of ~7% from 2020 to 2030. Emergence and adoption of technologically advanced instruments in life science, rise in demand for preventive healthcare, well-established healthcare facilities, rapidly increasing geriatric population, and high per capita healthcare expenditure are anticipated to drive the global microarray scanners market from 2020 to 2030. North America is expected to account for significant share of the global microarray scanners market during the forecast period. The growth of the market in the region can be attributed to well-established healthcare and life sciences industries, early adoption of technologically advanced products, high awareness about various infectious as well as chronic diseases, and high per capita healthcare expenditure.

 Request Brochure for Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45156

The market in Asia Pacific is likely to expand at a high CAGR from 2021 to 2031, due to the expansion of the healthcare sector in countries such as China, Japan, and India. Moreover, increase in drug research & development in countries such as Japan, India, and China is projected to propel the market in the region during the forecast period.

 Request for Analysis of COVID19 Impact on Microarray Scanners Market –


Rise in Awareness, Acceptance of Personalized Medicine, Companion Diagnostics to Propel Market

The demand for personalized medicine is increasing at a significant rate. Personalized medicine is defined as a practice of customization of an individual’s requirement using genetic profiling. Inclination toward personalized medicines can be ascribed to the efficiency and target-specific nature of medicines with better patient outcomes. According to a study published in the World Academy of Sciences Journal 2019, protein microarrays are paving the way for personalized medicine. Personalized medicine aims to stratify patients as per type of the disease, treatment response, evaluated prognosis, and its risk factors. Microarrays are being tried to develop personalized medicine for various disease types, including cell renal carcinoma, breast & ovarian cancers, and pulmonary diseases.

Additionally, targeted therapies have minimal or no side effects compared to conventional therapies. Significant sophistication in genomics research and biomarkers has encouraged several pharmaceutical companies to shift focus toward the development of novel targeted therapies. This accelerated adoption of companion diagnostics has led to a gradual decline of the traditional model.

Buy Market Report –


Fluorescence Microarray Scanners to Dominate Market

In terms of product type, the global microarray scanners market has been classified into fluorescence microarray scanners, charge-coupled devices microarray scanners, colorimetric microarray scanners, and others. The fluorescence microarray scanners segment is expected to dominate the global microarray scanners market by 2030. Fluorescence microarray scanners are highly common and widely utilized microarray detection devices. This is expected to drive the segment during the forecast period.

Gene Expression to be Highly Attractive Application

Based on application, the global microarray scanners market has been categorized into gene expression, drug discovery, and others. The gene expression segment is projected to dominate the global microarray scanners market during the forecast period. Application of gene expression for profiling for diseases, such as cardiovascular diseases including endothelial dysfunction, myocardial infarction, heart failure, cardiac hypertrophy, and atherosclerosis, is expected to drive the segment during the forecast period.

 Ask for Discount :


Diagnostic Laboratories to Account for Major Market Share

In terms of end user, the global microarray scanners market has been divided into hospitals, diagnostic laboratories, pharmaceutical & biotechnology companies, and academic & research institutes. The diagnostic laboratories segment is anticipated to account for a significant share of the global microarray scanners market by 2030. Diagnostic laboratories is expected to be a highly lucrative segment due to availability of facilities in diagnostics labs.

Competition Landscape in Microarray Scanners Market

The report provides profiles of leading players operating in the global microarray scanners market. These include Thermo Fisher Scientific, Agilent Technologies, Illumina, Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd., GE Healthcare (General Electric Company), Molecular Devices, LLC (Danaher Corporation), Innopsys Inc., and Berthold Technologies GmbH & Co. KG.

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/